Profile
Jakob Schlapbach worked as a Director at Cytos Biotechnology AG from 2011 to 2012.
He also worked as a Director at Lipideon Biotechnology AG and as the Chief Financial Officer at Ascom Holding AG and Cell Medica Switzerland AG.
Schlapbach earned an MBA from INSEAD in 1984 and an undergraduate degree from the University of Bern in 1979.
Former positions of Jakob Schlapbach
| Companies | Position | End |
|---|---|---|
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Director of Finance/CFO | 2011-01-12 |
| ASCOM HOLDING AG | Director of Finance/CFO | 1999-12-31 |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and distributes pharmaceutical, biological, medical, and diagnostic products | Director of Finance/CFO | - |
Lipideon Biotechnology AG
Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Researches and develops treatment of arteriosclerosis and related cardiovascular diseases | Director/Board Member | - |
Training of Jakob Schlapbach
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Ascom Holding AG
Ascom Holding AG Telecommunications EquipmentElectronic Technology Manufactures telecare IP monitoring systems and develops digistat & communication software | Electronic Technology |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bern
University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and distributes pharmaceutical, biological, medical, and diagnostic products | Health Technology |
Lipideon Biotechnology AG
Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Researches and develops treatment of arteriosclerosis and related cardiovascular diseases | Commercial Services |
- Stock Market
- Insiders
- Jakob Schlapbach
















